Potential protective role of ACE-inhibitors and AT1 receptor blockers against levodopa-induced dyskinesias: a retrospective case-control study

Growing evidence has highlighted that angiotensin-converting enzyme (ACE)-inhibitors (ACEi)/AT1 receptor blockers (ARBs) may influence the complex interplay between dopamine and the renin-angiotensin system in the nigrostriatal pathway, thus affecting the development of levodopa-induced dyskinesia i...

Descripción completa

Detalles Bibliográficos
Autores principales: Contaldi, Elena, Magistrelli, Luca, Milner, Anna V., Cosentino, Marco, Marino, Franca, Comi, Cristoforo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374578/
https://www.ncbi.nlm.nih.gov/pubmed/33907036
http://dx.doi.org/10.4103/1673-5374.313061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374578/
https://www.ncbi.nlm.nih.gov/pubmed/33907036
http://dx.doi.org/10.4103/1673-5374.313061

Ejemplares similares